Navigation Links
Better Drug for Heart Transplant

A new study shows the drug everolimus is better at reducing problems in heart transplant patients than one of the currently used drugs. Specifically the drug reduced the incidence of a serious disorder that can cause deterioration of the graft known as coronary vasculopathy.//

Previous studies have shown everolimus combined with another drug reduced the rejection and risk of infection in kidney transplant patients. Researchers from Temple University in Philadelphia conducted a study to determine if everolimus is also effective for heart transplant patients.

For the study, 634 patients were randomly assigned to receive one of two doses of everolimus or another drug, azathioprine, after having a heart transplant. The drugs were given once a day in combination with other standard treatments. Researchers followed patients for one year to determine if they had any complications from the transplant.

Researchers report the patients on either dose of everolimus fared much better than the patients on azathioprine. After one year, researchers say it was clear everolimus was significantly more effective than azathioprine in preventing vasculopathy. Study authors write, "Everolimus combined with cyclosporine and corticosteroids during the first 12 months is a safe and effective immunosuppressant regimen for use in recipients of a first heart transplant."

Researchers say further evaluation and follow-up are needed to determine the optimal dose. However, they say the findings of this study offer some optimism that everolimus is a promising agent for the management of rejection and vasculopathy after heart transplantation.
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Better Drug for Heart Transplant

(Date:11/25/2009)... have found evidence of a statistically significan...atients whose estrogen receptor (ER)-positive tumo... at serine-118 (ER-alpha S118-P), according to a b... the Journal of the National Cancer Institute . ,...stant to tamoxifen. Preclinical studies have shown...
(Date:11/25/2009)...low-up period was too short to draw definite concl.... 25 (HealthDay News) -- In diabetic patients with... difference in outcomes at one year whether patien...ting, British researchers report. , Bypass surg...atients with coronary artery disease. However, les...
(Date:11/25/2009)...etfulness could lead mothers to overlook needed ca...HealthDay News) -- A mother,s depression can worse... , Their six-month study of 262 black mothers a...s had more depressive symptoms had more frequent a...er depressive symptoms had less frequent asthma sy...
(Date:11/25/2009)...RK,Nov.25/PRNewswire/-- MISSIONSkincare ®ispr...rSt.Jude.AspartofGNC,sannualSt.Jude ThanksandGivin...incare,s new SUPER-C(TM)LipBalm willbedonatedtoS...tomakea$1,$5or$10donationatcheckoutatoneoftheir5,0...han$1millionforSt.Judeduringtheir2009 ThanksandGiv...
(Date:11/25/2009)...Mass. -- A cancer vaccine carried into the body on...is the first to successfully eliminate tumors in m... Science Translational Medicine . , The new app... at Harvard University, uses plastic disks impregn...der the skin to reprogram the mammalian immune sys...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...ing poorly one year later, study found , ,...attack is apparently not sufficient reason for mos...study finds. , "We found that diet quality is poor...al School, in Worcester. , But he warned that pati...
...s in young womens drinking during the transition f...can have dangerous physical, sexual and psychologi... University at Buffalos Research Institute on Addi...incoming freshmen women who participated in the st...
...Red Cross for Disaster Relief; Opens Free ... BRENTWOOD, Tenn., Feb. 8 Responding to the,deva...e earlier this week,UnitedHealthcare of the River ...ll Tennesseans who may be coping with the,emotiona...
...t sand boosts gastrointestinal illness risk, study...-- When you,re at the beach, you may want to stay ...sity of Florida researcher who conducted a two-yea...exposure to sand on the upper beach," Tonya D. Bon...
...e if its kind in the Pacific Northwest, SEATTLE, ...d Northwest Hospital & Medical Center today announ...he development of a new, state-of-the-art,cancer t...2006 and has since been working to secure financin...
...cot Financial, a leading,provider of convenient, c...o come out and have fun "the Amscot way" at its op...m. at 3260 Vineland Road in Kissimmee. Amscot,will... the disease., (Logo: http://www.newscom.com/cgi...
Other Medicine News:Health News:Heart Attack Seldom Leads to Healthier Diet 2Health News:Heart Attack Seldom Leads to Healthier Diet 3Health News:A dangerous transition: High school to the first year of college 2Health News:A dangerous transition: High school to the first year of college 3Health News:A dangerous transition: High school to the first year of college 4Health News:UnitedHealthcare of the River Valley Acts to Help Tennessee Victims of Storm Devastation 2Health News:UnitedHealthcare of the River Valley Acts to Help Tennessee Victims of Storm Devastation 3Health News:Staying Dry at Beach May Spare Your Stomach 2Health News:Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment 2Health News:Seattle Cancer Care Alliance and Northwest Hospital Sign Letter of Intent to Develop Proton Therapy Center for Cancer Treatment 3Health News:Amscot Financial Contributes to the Juvenile Diabetes Research Foundation, Supporting Upcoming 'Walk for a Cure' 2
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...e/--Inadditiontofamily,friendsandhealth,cancersurv...anksgivinggratitudelist. ,, "Theyheardthefactsa...Monday,sverdictstotaling$103millionindamagesagains...womennationwidewhohavesuedWyethandPfizerpharmaceut...mpro.Wisneskiandtheothervictimsofhormonetherapyhav...
(Date:11/24/2009)...-Accumetrics,Inc.,aprivately-helddeveloperandmarke...-to-usediagnosticsystemformeasuringanindividual,sr...4;andaspirin),announcedtodaythatTimothyI.Still,Pre...efFinancialOfficerofAccumetrics,willbepresentingac...areConferencebeingheldinNewYorkCityonDecember1-2,2...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 1As the Government Continues to Work Toward Health Care Reform Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right 52591 2Human cells secrete cancer killing protein UK study finds 52589 1Human cells secrete cancer killing protein UK study finds 52589 2Bcl6 gene sculpts helper T cell to boost antibody production 52587 1Bcl6 gene sculpts helper T cell to boost antibody production 52587 2
... Supports Replacement of Pap With HPV Test as Fron...hed in the International Journal of,Cancer show th... (HPV) DNA,test are half as likely to develop mode...years as those who get only conventional cytology ...000 women age 35 years and older,and assessed thei...
...ved positive results of nine month,PAINT trials fo...he results unveiled during plenary session o...Sahajanand Medical Technologies,Pvt. Ltd. (SMT), S...,drug-eluting stents, welcomed the positive result...s of PAINT trial (PercutAneous INTervention,with b...
Other Medicine Technology:Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 2Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 4Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3
MP20
... IntelliVue MP90 is designed to match the pace and...nts. Built on Philips strong heritage in patient m...nt displays has highly flexible screen configurati...-in clinical support tools such as Event Surveilla...
...xNet adds wireless capability to Welch Allyn's com... the Flexible Monitoring concept to provide vital ...o anywhere. FlexNet links multiple devices such as...reless bedside monitors to Acuity® Central Mon...
Spot Vital Signs
Medicine Products: